Assembly Biosciences Inc
NASDAQ:ASMB

Watchlist Manager
Assembly Biosciences Inc Logo
Assembly Biosciences Inc
NASDAQ:ASMB
Watchlist
Price: 17.08 USD -0.93% Market Closed
Market Cap: 130.5m USD

Intrinsic Value

ASMB's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ASMB stock under the Base Case scenario is 12.6 USD. Compared to the current market price of 17.08 USD, Assembly Biosciences Inc is Overvalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ASMB Intrinsic Value
12.6 USD
Overvaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Assembly Biosciences Inc

Valuation History Unavailable

Historical valuation for ASMB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare ASMB to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ASMB?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Assembly Biosciences Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Assembly Biosciences Inc

Current Assets 95.5m
Cash & Short-Term Investments 91m
Other Current Assets 4.5m
Non-Current Assets 3.5m
PP&E 3.2m
Other Non-Current Assets 312k
Efficiency

Free Cash Flow Analysis
Assembly Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Assembly Biosciences Inc

Revenue
32.2m USD
Operating Expenses
-76.8m USD
Operating Income
-44.6m USD
Other Expenses
4.7m USD
Net Income
-39.9m USD
Fundamental Scores

ASMB Profitability Score
Profitability Due Diligence

Assembly Biosciences Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
Exceptional Revenue Growth Forecast
Declining ROE
24/100
Profitability
Score

Assembly Biosciences Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

ASMB Solvency Score
Solvency Due Diligence

Assembly Biosciences Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
50/100
Solvency
Score

Assembly Biosciences Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ASMB Price Targets Summary
Assembly Biosciences Inc

Wall Street analysts forecast ASMB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASMB is 32.3 USD with a low forecast of 29.29 USD and a high forecast of 36.75 USD.

Lowest
Price Target
29.29 USD
71% Upside
Average
Price Target
32.3 USD
89% Upside
Highest
Price Target
36.75 USD
115% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Assembly Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ASMB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ASMB Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ASMB stock?

The intrinsic value of one ASMB stock under the Base Case scenario is 12.6 USD.

Is ASMB stock undervalued or overvalued?

Compared to the current market price of 17.08 USD, Assembly Biosciences Inc is Overvalued by 26%.

Back to Top